Study of HS-10542 in healthy volunteers
This trial tests an investigational drug, HS-10542, in healthy adults to see how it is processed by the body and to check for side effects. You must be willing to receive two vaccines before the study starts.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 64 years old.
- Your BMI is between 19 and 28, and you weigh at least 50 kg (men) or 45 kg (women).
- You can get the required vaccines (against meningitis and pneumonia) at least two weeks before the first dose.
- You agree to use effective birth control: women from 2 weeks before screening until 60 days after the last dose, men from signing consent until 120 days after the last dose.
- You have no serious health problems that would make the study unsafe, and you can follow the study rules.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called HS-20136-2 in healthy people to see how it works in the body and if it's safe. It's a Phase 1 study to gather early information before testing in patients.
This trial tests a single dose of a new medicine called HB0056 in healthy volunteers to evaluate its safety and how the body processes it. If you are a healthy adult, you may help doctors understand if this drug is safe for future studies.
This trial tests a new medicine called HS-20152 in healthy people to see if it is safe and how the body handles it. Participants will receive vaccinations before the study to protect against certain infections.
This study tests a new medicine called HS-10504 in healthy adults to see how the body processes it. It helps find the right dose and check for side effects.
This study looks at how a drug called HS-10504 is processed and eliminated from the body. Healthy male volunteers take one dose so researchers can track where the drug goes. It helps determine the right dosing and safety for future patients.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.